Alprazolam (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Alprazolam" in Serbian language version.

refsWebsite

Global rank Serbian rank

4nih.gov

4^th place

8^th place

3web.archive.org

1^st place

2rxlist.com

7,927^th place

3,501^st place

2google.ca

838^th place

391^st place

1guideline.gov

low place

5,669^th place

1fda.gov

447^th place

925^th place

1archive.org

6^th place

5^th place

1wiley.com

222^nd place

155^th place

1doi.org

2^nd place

4^th place

1books.google.com

3^rd place

2^nd place

1forbes.com

54^th place

151^st place

1samhsa.gov

low place

1drugs.com

399^th place

744^th place

1delrayrecoverycenter.com

low place

archive.org

Smith, R. B.; Kroboth, P. D.; Vanderlugt, J. T.; Phillips, J. P.; Juhl, R. P. (1984). „Pharmacokinetics and Pharmacodynamics of Alprazolam after Oral and IV Administration”. Psychopharmacology. 84 (4): 452—456. PMID 6152055.

books.google.com

Galanter, M. (1. 7. 2008). The American Psychiatric Publishing Textbook of Substance Abuse Treatment (4 изд.). American Psychiatric Publishing, Inc. стр. 222. ISBN 978-1-58562-276-4.

delrayrecoverycenter.com

„DEA brief Benzodiazepines”. Архивирано из оригинала 29. 10. 2013. г. Приступљено 26. 10. 2013. „Given the millions of prescriptions written for benzodiazepines (about 100 million in 1999), relatively few individuals increase their dose on their own initiative or engage in drug-seeking behavior.”

doi.org

Verster J. C.; Volkerts E. R. (2004). „Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature”. CNS Drug Rev. 10 (1): 45—76. PMID 14978513. doi:10.1111/j.1527-3458.2004.tb00003.x.

drugs.com

„Alprazolam”. The American Society of Health-System Pharmacists. Приступљено 3. 4. 2011.

fda.gov

accessdata.fda.gov

FDA (2011). „FDA approved labeling for Xanax revision08/23/2011” (PDF). Federal Drug Administration. стр. 4. Приступљено 14. 9. 2011.

forbes.com

Forbes. „The most prescibed drugs in the US”. Приступљено 9. 2. 2009.

google.ca

books.google.ca

Tampi, R. R.; Muralee, S.; Weder, N. D.; Penland, H., ур. (2008). Comprehensive review of psychiatry. Philadelphia, PA: Wolters Kluwer / Lippincott Williams & Wilkins Health. стр. 226. ISBN 9780781771764.
Pavuluri, M. N.; Janicak, P. G.; Marder, S. R. (2010). Principles and practice of psychopharmacotherapy (5th изд.). Philadelphia, PA: Wolters Kluwer Health / Lippincott Williams & Wilkins. стр. 535. ISBN 9781605475653.

guideline.gov

Work Group on Panic Disorder (2009). „APA Practice Guideline for the Treatment of Patients With Panic Disorder, Second Edition”. Архивирано из оригинала 05. 11. 2011. г. Приступљено 7. 12. 2009.

nih.gov

ncbi.nlm.nih.gov

Mandrioli R.; Mercolini L.; Raggi M. A. (2008). „Benzodiazepine metabolism: An analytical perspective”. Current drug metabolism. 9 (8): 827—844. PMID 18855614.
Sheehan, D. V.; Sheehan, K. H.; Raj, B. A. (2007). „The Speed of Onset of Action of Alprazolam-XR Compared to Alprazolam-CT in Panic Disorder”. Psychopharmacology Bulletin. 40 (2): 63—81. PMID 17514187.
Smith, R. B.; Kroboth, P. D.; Vanderlugt, J. T.; Phillips, J. P.; Juhl, R. P. (1984). „Pharmacokinetics and Pharmacodynamics of Alprazolam after Oral and IV Administration”. Psychopharmacology. 84 (4): 452—456. PMID 6152055.
Verster J. C.; Volkerts E. R. (2004). „Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature”. CNS Drug Rev. 10 (1): 45—76. PMID 14978513. doi:10.1111/j.1527-3458.2004.tb00003.x.

rxlist.com

First DataBank (2008). „Xanax (Alprazolam) clinical pharmacology - prescription drugs and medications at RxList”. RxList.
First DataBank (2008). „Xanax XR (Alprazolam) clinical pharmacology - prescription drugs and medications at RxList”. RxList.

samhsa.gov

United States Government (2006). „Drug Abuse Warning Network, 2006: National Estimates of Drug-Related Emergency Department Visits” (PDF). U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. Substance Abuse and Mental Health Services Administration. Архивирано из оригинала (PDF) 12. 03. 2012. г. Приступљено 9. 2. 2009.

web.archive.org

Work Group on Panic Disorder (2009). „APA Practice Guideline for the Treatment of Patients With Panic Disorder, Second Edition”. Архивирано из оригинала 05. 11. 2011. г. Приступљено 7. 12. 2009.
United States Government (2006). „Drug Abuse Warning Network, 2006: National Estimates of Drug-Related Emergency Department Visits” (PDF). U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. Substance Abuse and Mental Health Services Administration. Архивирано из оригинала (PDF) 12. 03. 2012. г. Приступљено 9. 2. 2009.
„DEA brief Benzodiazepines”. Архивирано из оригинала 29. 10. 2013. г. Приступљено 26. 10. 2013. „Given the millions of prescriptions written for benzodiazepines (about 100 million in 1999), relatively few individuals increase their dose on their own initiative or engage in drug-seeking behavior.”

wiley.com

onlinelibrary.wiley.com

Verster J. C.; Volkerts E. R. (2004). „Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature”. CNS Drug Rev. 10 (1): 45—76. PMID 14978513. doi:10.1111/j.1527-3458.2004.tb00003.x.